Axis Top Picks - Oct 2023
We are proud to share that our Axis Top Picks basket delivered impressive returns of 32% in the last one year, beating by a wide margin the 15%...
560 Views
Ajanta Pharma (AJP IN): Starts FY24 With Healthy Branded Generics Growth and Improving Margins
Ajanta Pharma has a positive business outlook due to accelerated revenue growth driven by India branded generics business, niche and complex...
396 Views
Axis Research Scorecard Report - August 2023
We are proud to share that we released several Top Sector Ideas during the month and we highly encourage you to refer to these exclusive reports
313 Views
Sumitomo Pharma (4506 JP): Pain Continues with Dwindling Sales; Trial Setback Worsens Outlook
In Q1FY24, Sumitomo's revenue plummeted 53% YoY to ¥76B. The company reported operating loss of ¥34B. The company’s schizophrenia drug candidate...
373 Views
Axis Top Picks for the month of September 2023
Axis Top Picks basket delivered impressive returns of 28% in the last one year, against the 8% return posted by Nifty 50, beating the benchmark by...
408 Views